News Industry News Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio April 03, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA Michael O'Riordan March 14, 2024
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News PCI Radiation Reduction Intervention Scores Big in Michigan L.A. McKeown February 15, 2024
News Daily News UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI L.A. McKeown February 06, 2024
Presentation Miami Valves 2024 Modern PCI: Achieve Optimal Treatment with AGENT DCB Presenter: Yiannis S. Chatzizisis February 03, 2024
Presentation Miami Valves 2024 AGENT™ Drug-Coated Balloon Presenter: John M. Lasala February 03, 2024
Presentation Miami Valves 2024 Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis Presenter: Thomas E. Noel February 01, 2024
Presentation Miami Valves 2024 AGENT DCB Clinical Data Presenter: Nicolas M. Van Mieghem February 01, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023